Stage 5 chronic kidney disease

Disease1 paper1 finding

Humans1

Associations

1

Semaglutide

downin humans1HR 0.447Low certainty

1 study

Semaglutide lowers the risk of stage 5 chronic kidney disease in humans (HR 0.447, 95% CI 0.230-0.872).
Humansin adults with ADPKD
Association of semaglutide use with kidney outcomes in adults with ADPKD: A propensity score-matched real-world study · Science progress · 26 Aug 2026

Semaglutide →

Latest

2

Journal of Cardiovascular MedicineHumans21 Sep

Outcomes of SGLT2 inhibitors after transcatheter mitral valve repair in patients with type 2 diabetes mellitus

SGLT2 inhibitors

Science ProgressHumans26 Aug

Association of semaglutide use with kidney outcomes in adults with ADPKD: A propensity score-matched real-world study